Cargando…
Making, Cloning, and the Expression of Human Insulin Genes in Bacteria: The Path to Humulin
In the mid- to late 1970s, recombinant deoxyribonucleic acid methods for cloning and expressing genes in E. coli were under intense development. The important question had become: Can humans design and chemically synthesize novel genes that function in bacteria? This question was answered in 1978 an...
Autor principal: | Riggs, Arthur D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152450/ https://www.ncbi.nlm.nih.gov/pubmed/33340315 http://dx.doi.org/10.1210/endrev/bnaa029 |
Ejemplares similares
-
Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar Insulin‐R with the US‐licensed Humulin® R formulation in healthy subjects: Results from the RHINE‐1 (Recombinant Human INsulin Equivalence‐1) study
por: Plum‐Mörschel, Leona, et al.
Publicado: (2022) -
Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar Insulin 70/30 with US‐licensed HUMULIN® 70/30 formulation in healthy subjects: Results from the RHINE‐3 (Recombinant Human
INsulin
Equivalence‐3) study
por: Plum‐Mörschel, Leona, et al.
Publicado: (2022) -
Treatment Patterns and Outcomes Before and After Humulin R U-500 Initiation Among US Patients with Type 2 Diabetes Previously Prescribed ≤ 200 Units/day of U-100 Insulin
por: Chen, Jieling, et al.
Publicado: (2022) -
Inducible expression of insulin receptors on T lymphocyte clones
Publicado: (1982) -
Human cloning laws, human dignity and the poverty of the policy making dialogue
por: Caulfield, Timothy
Publicado: (2003)